期刊文献+

296例胎儿生长受限临床分析 被引量:5

Clinical analysis of 296 cases of fetal growth restriction
下载PDF
导出
摘要 目的探讨胎儿生长受限发生的相关危险因素、终止妊娠的时机及方式,对围产儿结局的影响,为早期预防胎儿生长受限及改善围产儿结局提供临床参考。方法回顾性分析2007年7月至2011年6月间苏州大学附属第一人民医院收治的10070例单胎分娩孕妇的临床资料,其中296例胎儿生长受限,随机选取300例新生儿出生体重正常的孕妇做对照。结果①胎儿生长受限发病因素中,母体因素占56.1%,其中妊娠期高血压疾病为36.5%,在母体因素中所占比率最高,且高于对照组(Х^2=105.895,P〈0.05);②胎儿生长受限组中,经阴道分娩组的围产儿不良结局发生率(33.6%)显著高于剖宫产分娩组(8.5%)(Х^2=29.207,P〈0.05);③胎儿生长受限组胎儿窘迫、新生儿窒息、死胎率高于对照组,差异均有统计学意义(矿值分别为19.128、27.039、14.503,均P〈0.05);(少胎儿生长受限〈32周分娩或≥40周后分娩的严重不良围产儿结局发生率较高。结论加强围产期保健与筛查,积极治疗妊娠合并症及并发症,有助于及早发现、预防胎儿生长受限趋势并及早治疗。预产期前适时终止妊娠,适当放宽剖宫产指征,可改善围产儿预后。 Objective To explore the risk factors of fetal growth restriction (FGR) and the influence of the way and time of pregnancy termination on perinatal outcomes, so as to provide clinical references for preventing FGR and improve outcomes of FGR in clinics. Methods Clinical data of 296 cases with FGR in 10 070 pregnant women in First Affiliated Hospital to Soochow University from July 2007 to June 2011 was retrospectively analyzed. Meanwhile, 300 cases of pregnant women which had neonates with normal birth weight were chosen as control. Results In FGR cases, maternal factors accounted for 56.1% of pathogenesis of FGR, of which hypertensive disorders complicating pregnancy demonstrated the highest proportion ( 36.5% ) and was higher than that in control group (X^2 = 105. 895, P 〈 0.05 ). Incidence of adverse perinatal outcomes in vaginal delivery group (33.6%) was significantly higher than that in cesarean delivery group (8.5 % ). The incidence of fetal distress, neonatal asphyxia and stillbirth in FGR group was higher than that in control group, and the differences were significant (X2 value was 19. 128, 27. 039 and 14. 503, respectively, all P 〈 0. 05 ). The rate of adverse perinatal outcomes was relatively high in women with less than 32 or more than 40 gestational weeks. Conclusion Intensive perinatal healthcare and screening, management of pregnant complications will contribute early diagnosis, preventing the tendency of FGR and early treatment. Cesarean delivery before expected date of confinement can be considered to effectively improve the outcomes.
出处 《中国妇幼健康研究》 2012年第3期308-310,共3页 Chinese Journal of Woman and Child Health Research
关键词 胎儿生长受限 围产期保健 分娩方式 围产儿结局 fetal growth restriction (FGR) perinatal healthcare delivery mode perinatal outcomes
  • 相关文献

参考文献8

  • 1Mook K D O, Steegers E A, Eilers P H, et al. Risk factors and outcomes associated with first-trimester fetal growth restriction [ J ]. JAMA,2010,303 (6) :527-534.
  • 2Poon L C, Kametas N A, Pandeva I, et al. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeelampsia[ J]. Hypertension ,2008,51 (4) : 1027-1033.
  • 3王海燕,苟文丽.胎盘葡萄糖转运蛋白与胎儿生长受限[J].中国妇幼健康研究,2008,19(1):52-54. 被引量:1
  • 4Cetin I. Placental transport of amino acids in normal and growth- restricted pregnancies [ J ]. Eur J Obstet Gynecol Reprod Biol, 2003, 110( 11 ) :S50-S54.
  • 5Maulik D, Mundy D, Heitmann E, et al. Umbilical artery Doppler in the assessment of fetal growth restriction [ J ]. Clin Perinatol, 2011,38 ( 1 ) :65-82.
  • 6Salafia C M, Charles A K, Maas E M. Placenta and fetal growth restriction[ J]. Clin Obstet Gyneco1,2006,49 ( 2 ) :236-256.
  • 7Clausson B, Gardosi J, Francis, et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards[ J]. B JOG,2001,108 ( 8 ) : 830-834.
  • 8Damodaran-M, Story L, KulinSkaya E, et al. Early adverse perinatal complications in preterm growth-restricted fetuses [ J ]. Aust N Z J Obstet Gynaeco1,2011,51 ( 3 ) :204-209.

二级参考文献8

  • 1Wooding F B,Dantzer V B,Klisch K,et al.Glucose transporter 1 localisation throughout pregnancy in the carnivore placenta:Light and electron microscope studies[J].Placenta,2007,28(5-6):453-464.
  • 2Ericsson A,Hamark B,Powell T L,et al.Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placenta[J].Hum Reprod,2005,20(2):521-530.
  • 3Wooding F B,Fowden A L,Bell A W,et al.Localisation of glucose transport in the ruminant placenta:Implications for sequential use of transporter isoforms[J].Placenta,2005,26(8-9):626-640.
  • 4Baumann M U,Zamudio S,Illsley N P,et al.Hypoxic upreg-ulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1[J].Am J Physiol Cell Physiol,2007,293(1):C477-C485.
  • 5Ganguly A,McKnight R A,Raychaudhuri S,et al.Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction[J].Am J Physiol Endocrinol Metab,2007,292(5):E1241-E1255.
  • 6Jansson T,Powell T L.Human placental transport in altered fetal growth:Does the placenta function as a nutrient sensor? A review[J].Placenta,2006,27:S91-S97.
  • 7Zamudio S,Baumann M U,Illsley N P.Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters[J].Placenta,2006,27(1):49-55.
  • 8Korgun E T,Celik O C,Seval Y,et al.Do glucose transporters have other roles in addition to placental glucose transport during early pregnancy[J]?Histochem Cell Biol,2005,123(6):621-629.

同被引文献44

  • 1李元芹,陈建梅,严凌,陈玉兰,张玉梅,岑金芳.在437例高血压孕妇中胎儿生长受限的“权重”[J].现代生物医学进展,2009,9(24):4739-4741. 被引量:3
  • 2张青萍,赵蔚.二维、彩色多普勒超声诊断胎儿宫内发育迟缓[J].实用妇产科杂志,1996,12(3):122-123. 被引量:9
  • 3曹泽毅.中国妇产科学[M].北京:人民卫生出版社,1999..
  • 4谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 5Harding JE, Evans P, Gluckman P.Matemal growth homone treatment increase placental diffusion capacity but not fetal or placental growth in sheep[J].Endocridol, 1997,138 ( 15 ) : 5352-5358.
  • 6Meroni PL, Oisimone N, Testoni C, et al.Antiphospholipid antibodies as cause of pregnancy loss[J]. Lupus, 2004, 13 ( 9 ) : 649-652.
  • 7Baschat AA. Fetal growth restriction-from observation to intervention[M]. J Perinat Med, 2010,38(3) :239-246.
  • 8Hatem A, Mousa, Pam Loughna. Fetal growth restriction : Investigation and treatment[J]. Obstetrics Gynecology and Reproductive Medicine, 2008,18 (9) : 247-252.
  • 9黎淑琳.低分子肝素在胎儿生长受限治疗中的疗效分析[J].中外健康文摘,2013,10(24):229.
  • 10Babovic I,Plesinac S.Doppler examination in the evaluation of outcomes in pregnancies complicated by gestational hypertension and fetal intrauterine growth retardation-is it enough[J].Clin Exp Obstet Gynecol,2012,39(2):222-224.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部